Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (241-250 of 350) with videos related to

Pageof 35
Sort By:
Human Pathology|February 20, 2026
Epigenetic Profiling of Biphenotypic Sinonasal Sarcoma Across Fusion Variants and High-Grade TransformationYuri Merlotti Gomes, João Víctor Alves de Castro, Nicolai Merlotti Gomes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2018
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 TrialEugene I Hwang, Marcel Kool, Peter C Burger, et al.
Acta Neuropathologica|April 12, 2013
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 proteinLeonille Schweizer, Christian Koelsche, Felix Sahm, et al.
Acta Neuropathologica|July 11, 2014
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic gliomaBenedikt Wiestler, David Capper, Martin Sill, et al.
Nature Cell Biology|June 18, 2013
A complex secretory program orchestrated by the inflammasome controls paracrine senescenceJuan Carlos Acosta, Ana Banito, Torsten Wuestefeld, et al.
Nature Cell Biology|April 28, 2026
Author Correction: A complex secretory program orchestrated by the inflammasome controls paracrine senescenceJuan Carlos Acosta, Ana Banito, Torsten Wuestefeld, et al.
Acta Neuropathologica|March 23, 2021
TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymomaChristian Thomas, Felix Thierfelder, Malte Träger, et al.
Clinical Sarcoma Research|May 10, 2017
Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated casesChristian Koelsche, Daniel Schrimpf, Lars Tharun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 3, 2017
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma TrialKarsten Geletneky, Jacek Hajda, Assia L Angelova, et al.
Nature Cancer|June 6, 2025
crossNN is an explainable framework for cross-platform DNA methylation-based classification of tumorsDongsheng Yuan, Robin Jugas, Petra Pokorna, et al.
Pageof 35

Showing results (241-250 of 350) with videos related to

Sort By:
Pageof 35
Human Pathology|February 20, 2026
Epigenetic Profiling of Biphenotypic Sinonasal Sarcoma Across Fusion Variants and High-Grade TransformationYuri Merlotti Gomes, João Víctor Alves de Castro, Nicolai Merlotti Gomes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2018
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 TrialEugene I Hwang, Marcel Kool, Peter C Burger, et al.
Acta Neuropathologica|April 12, 2013
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 proteinLeonille Schweizer, Christian Koelsche, Felix Sahm, et al.
Acta Neuropathologica|July 11, 2014
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic gliomaBenedikt Wiestler, David Capper, Martin Sill, et al.
Nature Cell Biology|June 18, 2013
A complex secretory program orchestrated by the inflammasome controls paracrine senescenceJuan Carlos Acosta, Ana Banito, Torsten Wuestefeld, et al.
Nature Cell Biology|April 28, 2026
Author Correction: A complex secretory program orchestrated by the inflammasome controls paracrine senescenceJuan Carlos Acosta, Ana Banito, Torsten Wuestefeld, et al.
Acta Neuropathologica|March 23, 2021
TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymomaChristian Thomas, Felix Thierfelder, Malte Träger, et al.
Clinical Sarcoma Research|May 10, 2017
Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated casesChristian Koelsche, Daniel Schrimpf, Lars Tharun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 3, 2017
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma TrialKarsten Geletneky, Jacek Hajda, Assia L Angelova, et al.
Nature Cancer|June 6, 2025
crossNN is an explainable framework for cross-platform DNA methylation-based classification of tumorsDongsheng Yuan, Robin Jugas, Petra Pokorna, et al.
Pageof 35